Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Aleafia Health Inc. (AH) has appointed two new independent directors
  • The company hired Lu Galasso and Carlo Sistilli to its Board
  • Galasso will be appointed to the strategic planning committee
  • Sistilli will be appointed to the audit committee
  • Aleafia Health Inc. is up 1.41 per cent to C$0.72 per share

Aleafia Health Inc. (AH) has appointed two new independent directors.

The company hired Lu Galasso and Carlo Sistilli to its Board.

Galasso will be appointed to the strategic planning committee and Sistilli will be appointed to the audit committee.

“I would like to welcome Lu and Carlo to our Board,” said acting chair Lea Ray.

“Their collective professional experience will bring unique skills to the board that will serve Aleafia Health well in its continued growth.”

Galasso is a Chartered Professional Accountant, CA, CPA and holds the Institute of Corporate Directors ICD.D designation.

He is also a partner with the Zzen Group of Companies, a company in the real estate and manufacturing sectors, where he is the CFO and head of strategic developments for the manufacturing operations.

Sistilli is a Chartered Professional Accountant and a Certified Management Accountant, CPA, CMA. As Chief Financial Officer and member of the Senior Management team of Arista Homes, Sistilli played a key role in overall operations including evaluation of mergers and acquisitions.

Prior to Arista, Sistilli co-founded and served as CFO, member of the M&A team and member of the Board of Directors of an Internet start-up company, helping to take the company public on the Alberta Ventures Exchange.

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets.

Aleafia Health Inc. is up 1.41 per cent to C$0.72 per share.

More From The Market Herald

" Potent Ventures (CSE:POT) is now “The Gummy Project Inc.”

Potent Ventures (POT) has received shareholder and CSE approval for its change of business.
Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) reports Q4 and FY2022 financial results

Canopy Growth Corporation (WEED) has released its financial results for the fourth quarter and fiscal year ended March 31, 2022.